
How Obesity Actually Affects Breast Cancer Risk and Hormones
Obesity and breast cancer share a hormonal pathway — fat tissue produces estrogen via aromatase, competing with aromatase inhibitor therapy.
Sameer Patel is the founder and editor of My Medicine Advisor. He is not a doctor or medical professional — before starting this site he worked in banking, and he now researches and edits health information full-time.
He started My Medicine Advisor to make clear, well-sourced health information freely available to anyone. Every article is researched from recognised authorities such as the WHO, CDC, NIH, and NICE, drafted with the help of AI tools, and edited by hand, with sources linked so readers can check them. The calculators on the site use established, published formulas, each one named so you can look it up yourself.
My Medicine Advisor is currently a one-person operation with no clinical review panel, and the site is open about that. If you're a qualified clinician or researcher interested in reviewing content, Sameer would genuinely like to hear from you via the contact page.

Obesity and breast cancer share a hormonal pathway — fat tissue produces estrogen via aromatase, competing with aromatase inhibitor therapy.

Alcohol raises breast cancer risk 7–10% per drink — no safe threshold exists. See how estrogen, DNA damage, and BRCA status amplify that risk.

Breast cancer prevention changes dramatically once a Gail Model score reaches 1.7%. Many eligible women are never offered chemoprevention.

Lymphedema after breast cancer surgery can exist at Stage 0 — before swelling appears. NCCN 2026 names CDT as Category 1. A sleeve alone isn't enough.

Life after breast cancer has a clinical roadmap — most survivors never receive it. A gynecologist names the three care gaps survivors should close.

Recurrent breast cancer isn't one diagnosis — it's three. Local types aren't stage 4. CDK4/6 inhibitors now lead ER-positive distant recurrence treatment.

Stage 4 breast cancer treatment is now subtype-specific — T-DXd, CDK4/6 inhibitors, and PARP inhibitors matched to HER2, ER+, and BRCA status in 2026.

Dense breast tissue raises cancer risk 2.5x in BI-RADS D patients — and mammogram sensitivity can fall to 60–70% in dense tissue.

Egg freezing is clinically safe for ER+ breast cancer patients — a fact most premenopausal patients aren't told before their first oncology appointment.

Breast cancer during pregnancy carries a ~99% five-year survival rate at Stage I per 2026 NCI SEER data — but only when specialist care begins within 48 hours of diagnosis.